PRTN3 and rheumatoid arthritis: We significantly detected anti–cit-CRT Abs more frequently in the serum of ACPA+ RA patients compared with those with a negative ACPA status, expanding on recent data obtained in established RA patients (32) and suggesting that CRT acts as an autoantigen already in early stages of RA in a subset of patients.